memo - Magazine of European Medical Oncology
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Imaging and therapy targeting PSMA receptors for enhanced vision and precise treatment
memo - Magazine of European Medical Oncology - Tập 16 - Trang 251-254 - 2023
In Europe, it is estimated that more than 65,000 men die each year from the consequences of advanced and metastatic prostate cancer (PCa). Currently, approximately 3.2 million European men are living with PCa. While the majority of PCa patients have favorable outcomes, the 5‑year relative survival rate for those with metastatic PCa is only 32%. Recent advances in the diagnosis of PCa have been boo......
Neurooncology: current findings and challenges for the future
memo - Magazine of European Medical Oncology - Tập 6 - Trang 225-226 - 2013
(Neo)adjuvant approaches in lung cancer—paving the road to a cure
memo - Magazine of European Medical Oncology - Tập 17 - Trang 10-14 - 2024
Immune checkpoint inhibitors (ICI) have revolutionized the treatment landscape of metastatic non-small-cell lung cancer (NSCLC). During the past few years the focus of research has shifted toward examining these therapies in patients with early-stage NSCLC to improve long-term overall survival and cure rates. As recurrence rates are high and the relapse pattern in patients with completely resected......
CAR-T cells in multiple myeloma: current status
memo - Magazine of European Medical Oncology - Tập 13 - Trang 43-49 - 2020
Starting with the approval of bortezomib, a proteasome-inhibiting drug, tremendous progress has been achieved in the treatment of multiple myeloma (MM) patients during the last 15 years. Due to a plethora of novel drugs such as second generation proteasome inhibitors, immunomodulating agents and monoclonal antibodies the 5‑year survival of MM patients has been extended from 33% at the turn of the ......
Small cell lung cancer
memo - Magazine of European Medical Oncology - Tập 1 - Trang 243-245 - 2008
SCLC is a life-threatening disease, typically caused by cigarette smoking. The incidence has been decreasing during the past decades, probably due to changes in smoking habits. The disease is mostly diagnosed in advanced stage and therefore requires systemic treatment and radiotherapy. Chemotherapy is the most important treatment intervention and a combination of cisplatin + etoposide (EP) represe......
Aggressive lymphoma: news on ASH 2014
memo - Magazine of European Medical Oncology - Tập 8 - Trang 170-171 - 2015
This article reviews the most important news at American Society of Hematology (ASH) 2014 for the clinician. A validated risk model for central nervous system (CNS) relapse after rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) defined a low, intermediate, and a high risk group. The latter with a CNS-relapse risk of 12 %. Interim positron emission tomography (PET) ima......
CECOG’s services at a glance
memo - Magazine of European Medical Oncology - Tập 3 - Trang 41-41 - 2010
Treatment options in localised and metastatic renal cell carcinoma
memo - Magazine of European Medical Oncology - Tập 1 - Trang 167-170 - 2008
Renal cell cancer (RCC) accounts for 2% of all malignancies. RCC shows a rising incidence and overall mortality is the highest among all urologic malignancies. In localised disease, radical cancer surgery remains the only potential curative treatment option. Indications for nephron-sparing surgery include renal tumours 4 cm or less in diameter and patients with solitary kidneys or bilateral synchr......
Tổng số: 854
- 1
- 2
- 3
- 4
- 5
- 6
- 10